1-6 of 6
Guenther G. Steger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer

Sherko Kuemmel, Mario Campone, Delphine Loirat, Rafael Lopez Lopez, J. Thaddeus Beck, Michelino De Laurentiis, Seock-Ah Im, Sung-Bae Kim, Ava Kwong, Guenther G. Steger, Esther Zamora Adelantado, Francois P. Duhoux, Richard Greil, Irene Kuter, Yen-Shen Lu, Ariadna Tibau, Mustafa Özgüroğlu, Christian W. Scholz, Christian F. Singer, Estela Vega, Pauline Wimberger, Claudio Zamagni, Xuan-Mai Couillebault, Liqiong Fan, Nelson Guerreiro, Jennifer Mataraza, Janna Sand-Dejmek, Arlene Chan
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (1): 106–115.
https://doi.org/10.1158/1078-0432.CCR-20-3955
Published: 05 January 2022
View article titled, A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer
Open the PDF for A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases

Elisabeth S. Bergen, Anna S. Berghoff, Mela Medjedovic, Margaretha Rudas, Florian Fitzal, Zsuzsanna Bago-Horvath, Karin Dieckmann, Robert M. Mader, Ruth Exner, Michael Gnant, Christoph C. Zielinski, Guenther G. Steger, Matthias Preusser, Rupert Bartsch
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (9): 2737–2744.
https://doi.org/10.1158/1078-0432.CCR-18-1968
Published: 01 May 2019
View article titled, Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases
Open the PDF for Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases in another window
Includes: Supplementary data
Journal Articles

Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer

Christian F. Singer, Yen Y. Tan, Florian Fitzal, Guenther G. Steger, Daniel Egle, Angelika Reiner, Margaretha Rudas, Farid Moinfar, Christine Gruber, Edgar Petru, Rupert Bartsch, Kristina A. Tendl, David Fuchs, Michael Seifert, Ruth Exner, Marija Balic, Zsuzsanna Bago-Horvath, Martin Filipits, Michael Gnant
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (14): 3676–3683.
https://doi.org/10.1158/1078-0432.CCR-16-2373
Published: 13 July 2017
View article titled, Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer
Open the PDF for Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract A12: Differential micro-RNA expression in a multistage 5-fluorouracil resistant colon cancer model

Robert M. Mader, Matthias Wieser, Walter Berger, Maria Kalipciyan, Matthias Hackl, Guenther G. Steger, Johannes Grillari
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7_Supplement): A12.
https://doi.org/10.1158/1078-0432.TCME10-A12
Published: 02 February 2016
View article titled, Abstract A12: Differential micro-RNA expression in a multistage 5-fluorouracil resistant colon cancer model
Journal Articles

Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy

Allan Lipton, Guenther G. Steger, Jazmin Figueroa, Cristina Alvarado, Philippe Solal-Celigny, Jean Jacques Body, Richard de Boer, Rossana Berardi, Pere Gascon, Katia S. Tonkin, Robert E. Coleman, Alexander H.G. Paterson, Guozhi M. Gao, Amy C. Kinsey, Mark C. Peterson, Susie Jun
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6690–6696.
https://doi.org/10.1158/1078-0432.CCR-07-5234
Published: 16 October 2008
View article titled, Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy
Open the PDF for Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy in another window
Journal Articles

Her2 and Progesterone Receptor Status Are Not Predictive of Response to Fulvestrant Treatment

Rupert Bartsch, Catharina Wenzel, Gabriela Altorjai, Ursula Pluschnig, Robert M. Mader, Michael Gnant, Raimund Jakesz, Margaretha Rudas, Christoph C. Zielinski, Guenther G. Steger
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (15): 4435–4439.
https://doi.org/10.1158/1078-0432.CCR-06-3050
Published: 01 August 2007
View article titled, Her2 and Progesterone Receptor Status Are Not Predictive of Response to Fulvestrant Treatment
Open the PDF for Her2 and Progesterone Receptor Status Are Not Predictive of Response to Fulvestrant Treatment in another window